American Scientific Resources Announces Addition of New Board Member
October 22 2009 - 6:30AM
PR Newswire (US)
WESTON, Fla., Oct. 22 /PRNewswire-FirstCall/ -- American Scientific
Resources, Inc. (Pink Sheets: ASFX), today announced the addition
of a new member to the Company's board of directors: Mr. Jason
Roth, the Company's newly appointed Senior Vice-President and
Director of Business Development. Mr. Roth, a successful
entrepreneur & marketing specialist in the medical supply
industry, has taken great strides to advance the Company's brand
and provide for an additional revenue channel by introducing the
world's only FDA approved home needle destruction device, the
Disintegrator Plus(TM), to ASR who acquired the exclusive selling
and intellectual property rights from Safeguard Medical
Technologies LLC. Dr. Christopher F. Tirotta, CEO for American
Scientific commented, "We are pleased to welcome Jason to the Board
and look forward to seeing the results derived from his contacts
and expertise." About American Scientific Resources, Inc. American
Scientific Resources, Inc. is the parent company for wholly-owned
subsidiaries, Kidz-Med and Heart Smart System. The Company's
objective is to locate and acquire innovative health and safety
products that are successfully sold abroad, and to introduce and
promote them to the North American market. More information about
the Company, including financial information, can be found on the
ASFX web site at http://www.americansci.com/. For product
information, visit the Company's subsidiary, Kidz-Med at
http://www.kidzmed.com/. Safe Harbor This release may contain
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Statements contained in
this release that are not historical facts may be deemed to be
forward-looking statements. Investors are cautioned that
forward-looking statements are inherently uncertain. Actual
performance and results may differ materially from that projected
or suggested herein due to certain risks and uncertainties
including, without limitation, ability to obtain financing and
regulatory and shareholder approvals for anticipated actions.
Contact: Ronald Garner Investor Hotline: 619-293-0621 DATASOURCE:
American Scientific Resources, Inc. CONTACT: Ronald Garner,
Investor Hotline: +1-619-293-0621, Web Site:
http://www.americansci.com/
Copyright